Jing Wang, M.D., Ph.D. - Publications

Affiliations: 
Harbin Medical University, China Harbin Medical University, China, Haerbin Shi, Heilongjiang Sheng, China 
Area:
Electrophysiology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. PMID 27372738 DOI: 10.1016/J.Cell.2016.05.069  0.31
2016 Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, Wang X, Qiao JW, Cao S, Petralia F, Kawaler E, Mundt F, Krug K, Tu Z, Lei JT, ... ... Wang J, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 534: 55-62. PMID 27251275 DOI: 10.1038/Nature18003  0.317
2016 Mertins P, Mani, Ruggles K, Gillette M, Clauser K, Wang P, Wang X, Qiao J, Cao S, Petralia F, Mundt F, Tu Z, Lei J, Gatza M, Wilkerson M, ... ... Wang J, et al. Abstract IA29: Proteogenomic and phosphoproteomic analysis of breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-Ia29  0.327
2015 Qian J, Hassanein M, Hoeksema MD, Harris BK, Zou Y, Chen H, Lu P, Eisenberg R, Wang J, Espinosa A, Ji X, Harris FT, Rahman SM, Massion PP. The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers. Proceedings of the National Academy of Sciences of the United States of America. 112: 3469-74. PMID 25733852 DOI: 10.1073/Pnas.1421975112  0.314
2014 Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ, Shaddox KF, Kim S, Davies SR, Wang S, Wang P, Kinsinger CR, Rivers RC, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 513: 382-7. PMID 25043054 DOI: 10.1038/Nature13438  0.331
2014 Burrage LC, Tang S, Wang J, Donti TR, Walkiewicz M, Luchak JM, Chen LC, Schmitt ES, Niu Z, Erana R, Hunter JV, Graham BH, Wong LJ, Scaglia F. Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene. Molecular Genetics and Metabolism. 113: 207-12. PMID 25037980 DOI: 10.1016/J.Ymgme.2014.06.004  0.3
2014 Halvey PJ, Wang X, Wang J, Bhat AA, Dhawan P, Li M, Zhang B, Liebler DC, Slebos RJ. Proteogenomic analysis reveals unanticipated adaptations of colorectal tumor cells to deficiencies in DNA mismatch repair. Cancer Research. 74: 387-97. PMID 24247723 DOI: 10.1158/0008-5472.Can-13-2488  0.32
2013 Chanprasert S, Wang J, Weng SW, Enns GM, Boué DR, Wong BL, Mendell JR, Perry DA, Sahenk Z, Craigen WJ, Alcala FJ, Pascual JM, Melancon S, Zhang VW, Scaglia F, et al. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. Molecular Genetics and Metabolism. 110: 153-61. PMID 23932787 DOI: 10.1016/J.Ymgme.2013.07.009  0.3
2013 Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Research. 41: W77-83. PMID 23703215 DOI: 10.1093/Nar/Gkt439  0.307
2013 Tang S, Wang J, Zhang VW, Li FY, Landsverk M, Cui H, Truong CK, Wang G, Chen LC, Graham B, Scaglia F, Schmitt ES, Craigen WJ, Wong LJ. Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects. Human Mutation. 34: 882-93. PMID 23463613 DOI: 10.1002/Humu.22307  0.306
2012 Lee IC, El-Hattab AW, Wang J, Li FY, Weng SW, Craigen WJ, Wong LJ. SURF1-associated Leigh syndrome: a case series and novel mutations. Human Mutation. 33: 1192-200. PMID 22488715 DOI: 10.1002/Humu.22095  0.306
2011 Tang S, Wang J, Lee NC, Milone M, Halberg MC, Schmitt ES, Craigen WJ, Zhang W, Wong LJ. Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. Journal of Medical Genetics. 48: 669-81. PMID 21880868 DOI: 10.1136/Jmedgenet-2011-100222  0.322
2011 Wang J, Zhang Y, Shen X, Zhu J, Zhang L, Zou J, Guo Z. Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control. Molecular Biosystems. 7: 1158-66. PMID 21279201 DOI: 10.1039/C0Mb00211A  0.326
2011 Häberle J, Shchelochkov OA, Wang J, Katsonis P, Hall L, Reiss S, Eeds A, Willis A, Yadav M, Summar S, Lichtarge O, Rubio V, Wong LJ, Summar M. Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Human Mutation. 32: 579-89. PMID 21120950 DOI: 10.1002/Humu.21406  0.305
2010 Zhu J, Shen XP, Xiao H, Zhang Y, Wang J, Guo Z. [Identifying candidate cancer genes based on co-evolving gene modules]. Yi Chuan = Hereditas. 32: 694-700. PMID 20650850 DOI: 10.3724/Sp.J.1005.2010.00694  0.332
2010 Zhu J, Xiao H, Shen X, Wang J, Zou J, Zhang L, Yang D, Ma W, Yao C, Gong X, Zhang M, Zhang Y, Guo Z. Viewing cancer genes from co-evolving gene modules. Bioinformatics (Oxford, England). 26: 919-24. PMID 20176579 DOI: 10.1093/Bioinformatics/Btq055  0.323
2008 Li Y, Guo Z, Peng C, Liu Q, Ma W, Wang J, Yao C, Zhang M, Zhu J. Identifying cancer genes from cancer mutation profiles by cancer functions. Science in China. Series C, Life Sciences. 51: 569-74. PMID 18488178 DOI: 10.1007/S11427-008-0072-2  0.322
Show low-probability matches.